Covidien and Mallinckrodt to Present at Goldman Sachs Conference
Covidien and Mallinckrodt to Present at Goldman Sachs Conference
MANSFIELD, Mass.--(BUSINESS WIRE)-- Covidien (NYS: COV) , a leading global provider of healthcare products, will present at the Goldman Sachs 34th Global Healthcare Conference in Rancho Palos Verdes, CA, on Wednesday, June 12, 2013.
José E. Almeida, Chairman, President and Chief Executive Officer, will represent the Company in a session scheduled to begin at 12:20 p.m. ET.
Mark Trudeau, President, Pharmaceuticals, will discuss Mallinckrodt, the pharmaceuticals business of Covidien, in a session scheduled to begin at 4:20 p.m. ET.
A live audio webcast of the presentations can be accessed at Covidien's Investor Relations website: http://investor.covidien.com.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
Covidien
Jacqueline Strayer, 508-261-8305
Senior Vice President
Corporate Communications
jacqueline.strayer@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Todd Carpenter, 508-452-4363
Senior Director
Investor Relations
todd.carpenter@covidien.com
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS:
The article Covidien and Mallinckrodt to Present at Goldman Sachs Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
